DOSING DETAILS   

Study Dosing Objective:  Effective Dose, Safety Profile

Established Protocol:  Effective dose with adverse effects

Route of Administration: 

Cannabinoid Ratio:  (Pharma CBD : Pharma THC : Pharma THC:CBD)   0 : 0 : 0    

Clinical Relevance:  Cannabidiol is associated with a 50% reduction in seizure rate, clinical improvement in Dravat syndrome, and caregiver global impression of change, but may also reduce appetite.

Adverse Events:  20 mg/kg/d CBD results in a significant, elevated risk for decreased appetite 10 mg/kg/d might result in a mild elevation in the risk

Citation: